Piper Sandler Sticks to Its Buy Rating for Alignment Healthcare (ALHC)
TipRanks (Tue, 13-Jan 7:26 AM ET)
Alignment Healthcare (ALHC) Gets a Hold from Barclays
TipRanks (Tue, 13-Jan 4:56 AM ET)
Alignment Healthcare: Sustained Membership Growth and Expanding EBITDA Support Buy Rating
TipRanks (Mon, 12-Jan 9:25 PM ET)
Alignment Healthcare Reports Strong Medicare Advantage Membership Growth
TipRanks (Mon, 12-Jan 9:44 AM ET)
Alignment Healthcare guides 2026 membership growth up to 27%
Seeking Alpha News (Mon, 12-Jan 9:21 AM ET)
Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275,300 as of Jan. 1, 2026
Globe Newswire (Mon, 12-Jan 8:30 AM ET)
Top small and mid-cap ideas with 27% average upside potential – BoA
Seeking Alpha News (Fri, 9-Jan 12:49 PM ET)
Alignment Healthcare to Present at the 44th Annual J.P. Morgan Healthcare Conference
Globe Newswire (Wed, 17-Dec 8:00 AM ET)
Alignment Healthcare to Present at Piper Sandler 37th Annual Healthcare Conference
Globe Newswire (Wed, 19-Nov 8:00 AM ET)
Globe Newswire (Thu, 30-Oct 4:01 PM ET)
Alignment Healthcare Inc is a next-generation, consumer-centric platform that is revolutionizing the healthcare experience for seniors through Medicare Advantage plans. These plans are marketed and sold direct-to-consumer, allowing seniors to select the manner in which customers receive healthcare coverage and services on an annual basis. The company combines a technology platform and clinical model for more effective health outcomes.
Alignment Healthcare trades on the NASDAQ stock market under the symbol ALHC.
As of January 13, 2026, ALHC stock price declined to $21.13 with 469,972 million shares trading.
ALHC has a beta of 0.37, meaning it tends to be less sensitive to market movements. ALHC has a correlation of 0.02 to the broad based SPY ETF.
ALHC has a market cap of $4.23 billion. This is considered a Mid Cap stock.
Last quarter Alignment Healthcare reported $994 million in Revenue and $.02 earnings per share. This beat revenue expectation by $13 million and exceeded earnings estimates by $.05.
In the last 3 years, ALHC traded as high as $21.68 and as low as $4.46.
The top ETF exchange traded funds that ALHC belongs to (by Net Assets): IWM, VTI, VB, VBK, IWO.
ALHC has outperformed the market in the last year with a price return of +77.9% while the SPY ETF gained +20.6%. ALHC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +22.1% and +11.6%, respectively, while the SPY returned +6.4% and +0.7%, respectively.
ALHC support price is $20.76 and resistance is $21.80 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALHC shares will trade within this expected range on the day.